Literature DB >> 20069432

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.

Stefanie Burghaus1, Annett Hölsken, Michael Buchfelder, Rudolf Fahlbusch, Beat M Riederer, Volkmar Hans, Ingmar Blümcke, Rolf Buslei.   

Abstract

Craniopharyngiomas (CP) are benign epithelial tumors of the sellar region and can be clinicopathologically distinguished into adamantinomatous (adaCP) and papillary (papCP) variants. Both subtypes are classified according to the World Health Organization grade I, but their irregular digitate brain infiltration makes any complete surgical resection difficult to obtain. Herein, we characterized the cellular interface between the tumor and the surrounding brain tissue in 48 CP (41 adaCP and seven papCP) compared to non-neuroepithelial tumors, i.e., 12 cavernous hemangiomas, 10 meningiomas, and 14 metastases using antibodies directed against glial fibrillary acid protein (GFAP), vimentin, nestin, microtubule-associated protein 2 (MAP2) splice variants, and tenascin-C. We identified a specific cell population characterized by the coexpression of nestin, MAP2, and GFAP within the invasion niche of the adamantinomatous subtype. This was especially prominent along the finger-like protrusions. A similar population of presumably astroglial precursors was not visible in other lesions under study, which characterize them as distinct histopathological feature of adaCP. Furthermore, the outer tumor cell layer of adaCP showed a distinct expression of MAP2, a novel finding helpful in the differential diagnosis of epithelial tumors in the sellar region. Our data support the hypothesis that adaCP, unlike other non-neuroepithelial tumors of the central nervous system, create a tumor-specific cellular environment at the tumor-brain junction. Whether this facilitates the characteristic infiltrative growth pattern or is the consequence of an activated Wnt signaling pathway, detectable in 90% of these tumors, will need further consideration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20069432     DOI: 10.1007/s00428-009-0873-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  59 in total

1.  Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.

Authors:  Shigeki Sekine; Tatsuhiro Shibata; Akiko Kokubu; Yukio Morishita; Masayuki Noguchi; Yukihiro Nakanishi; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Distribution of nestin immunoreactivity in the normal adult human forebrain.

Authors:  Huaiyu Gu; Shuxing Wang; Conrad A Messam; Zhibin Yao
Journal:  Brain Res       Date:  2002-07-12       Impact factor: 3.252

3.  beta-Catenin regulates the expression of tenascin-C in human colorectal tumors.

Authors:  Katharina Beiter; Elke Hiendlmeyer; Thomas Brabletz; Falk Hlubek; Angela Haynl; Claudia Knoll; Thomas Kirchner; Andreas Jung
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

4.  Isolation of multipotent adult stem cells from the dermis of mammalian skin.

Authors:  J G Toma; M Akhavan; K J Fernandes; F Barnabé-Heider; A Sadikot; D R Kaplan; F D Miller
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

5.  Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach.

Authors:  Bernd M Hofmann; Jürgen Kreutzer; Wolfgang Saeger; Michael Buchfelder; Ingmar Blümcke; Rudolf Fahlbusch; Rolf Buslei
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

Review 6.  Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.

Authors:  David A Reardon; Michael R Zalutsky; Darell D Bigner
Journal:  Expert Rev Anticancer Ther       Date:  2007-05       Impact factor: 4.512

7.  Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis.

Authors:  Melissa A Cosenza; Meng-Liang Zhao; Sai L Shankar; Bridget Shafit-Zagardo; Sunhee C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2002-12       Impact factor: 8.090

Review 8.  Craniopharyngiomas.

Authors:  Niki Karavitaki; Simon Cudlip; Christopher B T Adams; John A H Wass
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

9.  Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.

Authors:  Keisuke Kato; Yukio Nakatani; Hiroshi Kanno; Yoshiyuki Inayama; Rieko Ijiri; Noriyuki Nagahara; Tetsumi Miyake; Mio Tanaka; Yumi Ito; Noriko Aida; Katsuhiko Tachibana; Ken-ichi Sekido; Yukichi Tanaka
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

10.  Surgical management of giant craniopharyngiomas.

Authors:  R Fahlbusch; B M Hofmann
Journal:  Acta Neurochir (Wien)       Date:  2008-11-11       Impact factor: 2.216

View more
  15 in total

1.  Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

Authors:  Annett Hölsken; Christina Stache; Sven Martin Schlaffer; Jörg Flitsch; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 2.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

3.  Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.

Authors:  Carolin Muth; Yvonne Rubner; Sabine Semrau; Paul-Friedrich Rühle; Benjamin Frey; Annedore Strnad; Rolf Buslei; Rainer Fietkau; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2015-12-08       Impact factor: 3.621

4.  Surgical strategies in childhood craniopharyngioma.

Authors:  Jörg Flitsch; Hermann Lothar Müller; Till Burkhardt
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-23       Impact factor: 5.555

5.  Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.

Authors:  Cynthia L Andoniadou; Carles Gaston-Massuet; Rukmini Reddy; Ralph P Schneider; Maria A Blasco; Paul Le Tissier; Thomas S Jacques; Larysa H Pevny; Mehul T Dattani; Juan Pedro Martinez-Barbera
Journal:  Acta Neuropathol       Date:  2012-02-18       Impact factor: 17.088

6.  EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.

Authors:  Vivian Thimsen; Annett Hölsken; Michael Buchfelder; Jörg Flitsch; Rudolf Fahlbusch; Harald Stefanits; Marco Losa; David T W Jones; Rolf Buslei
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

7.  Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.

Authors:  Annett Hölsken; Martin Sill; Jessica Merkle; Leonille Schweizer; Michael Buchfelder; Jörg Flitsch; Rudolf Fahlbusch; Markus Metzler; Marcel Kool; Stefan M Pfister; Andreas von Deimling; David Capper; David T W Jones; Rolf Buslei
Journal:  Acta Neuropathol Commun       Date:  2016-02-29       Impact factor: 7.801

Review 8.  Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biology.

Authors:  John Richard Apps; Juan Pedro Martinez-Barbera
Journal:  Brain Pathol       Date:  2017-05       Impact factor: 6.508

9.  Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.

Authors:  Annett Hölsken; Marc Schwarz; Clarissa Gillmann; Christina Pfister; Michael Uder; Arnd Doerfler; Michael Buchfelder; Sven Schlaffer; Rudolf Fahlbusch; Rolf Buslei; Tobias Bäuerle
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 10.  Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.

Authors:  Jie Wu; Xiao Wu; You Qing Yang; Han Ding; Le Yang; You Yuan Bao; Lin Zhou; Chen Xing Yang; Tao Hong
Journal:  Neurosurg Rev       Date:  2021-06-22       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.